The webinars provided by the International Society of Antimicrobial Chemotherapy (ISAC) are for informational purposes only. No material contained herein is intended to be a substitute for professional medical advice, diagnosis, treatment or national / local guidelines.
The opinions expressed in a webinar are those of the author(s) only and may not necessarily represent the views of ISAC. Where links are provided to other sites and resources of third parties, these links are provided for your information only. ISAC neither endorses not accepts responsibility for the contents of those sites or resources.
Antimicrobial stewardship in critical care units
Hear from ISAC President Prof. Souha Kanj and three renowned international experts as they explore cutting-edge strategies to optimise antimicrobial use in ICUs in this webinar hosted by ISAC and the Alliance for the Prudent Use of Antibiotics (APUA).
Gain insights on balancing effective treatment with resistance prevention in high-risk settings. A must-watch for infectious disease specialists, intensivists and pharmacists.
The aim of this session is to enhance your stewardship practices and improve patient outcomes.
Emerging and re-emerging infections among migrants
This ISAC webinar focused on respiratory infectious diseases in refugees, providing insight into the epidemiology, prevention, and management of important pathogens. Dr Androulla Efstratiou, Director of the WHO Collaborating Centre for Diphtheria & Streptococcal Infections, UK Health Security Agency, presented on diphtheria and other vaccine preventable diseases, while Dr Aula Abbara, a consultant in Infectious Diseases and General Internal Medicine at Imperial College NHS Healthcare Trust, London, who has worked in many humanitarian and refugee settings in the Middle East, reviewed drug resistant tuberculosis among refugees and migrants.
Artificial intelligence in Anti-Infectives
Artificial intelligence (AI) can support antimicrobial treatment decisions by rapidly analysing large volumes of patient data, laboratory results, and local resistance patterns to recommend the most effective and targeted antibiotics. By integrating real-time information from electronic health records, AI can help clinicians choose optimal treatments while avoiding unnecessary or broad-spectrum antibiotic use. Additionally, AI systems can detect emerging trends in antimicrobial resistance, allowing for early intervention and improved infection control measures. This contributes to better stewardship of existing antibiotics and helps prevent the spread of resistant pathogens in both healthcare settings and the community”. Our two eminent speakers provide real and timely intelligence on how much of this is possible now, what we may expect in the future, and how humans should use AI tools.
Bacteriophage therapy: where are we now?
ISAC / ESCMID
This session brings together two leading experts to share the latest research, clinical perspectives, and practical strategies for fostering interdisciplinary dialogue and accelerating the clinical adoption of phage therapy. Whether you're a researcher, clinician, or industry professional, this is your chance to stay at the forefront of a rapidly evolving field.
